biotech · Chronic Inducible Urticaria · Chronic Spontaneous Urticaria · JSPR
Jasper Therapeutics
Jasper Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Redwood City, CA, US HQ
44 Employees
Public company Type
JSPR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Redwood City, CA, US
- Employees
- 44
- Programs
- 13
- Drugs
- 13
- Patents
- 1
Jasper Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Jasper Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Jasper Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Jasper Therapeutics.
-
JSP-CP-011 — Phase 2
Clinical update -
JSP-CP-012 — Phase 1
Clinical update -
EPINEPHRINE , Briquilimab — Phase 2
Clinical update -
Nicotine patch — Phase 3
Clinical update -
Nelfinavir and Omeprazole — Approved
Clinical update -
Briquilimab — Phase 2
Clinical update -
Humanized anti-CD117 Monoclonal Antibody (JSP191) — Phase 2
Clinical update -
Humanized anti-CD117 Monoclonal Antibody (JSP191) — Phase 1
Clinical update